We are live on ! Find out more
MBIO icon

Mustang Bio

64 hedge funds and large institutions have $24M invested in Mustang Bio in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 5

16% more funds holding

Funds holding: 5564 (+9)

0% less ownership

Funds ownership: 0.03%0.03% (-0%)

7% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 15

33% less capital invested

Capital invested by funds: $35.8M → $24M (-$11.8M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $122K

Holders
64
Holders Change
+9
Holders Change %
+16.36%
% of All Funds
1.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
14
Reduced
15
Closed
5
Calls
Puts
$122K
Net Calls
-$122K
Net Calls Change
-$232K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$5.2M
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.7M +$5.13K +2 +0.1%
Renaissance Technologies
3
Renaissance Technologies
New York
$2.21M +$200K +78 +8%
State Street
4
State Street
Massachusetts
$1.32M -$7.69K -3 -0.5%
6CM
5
683 Capital Management
New York
$1.23M
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.09M +$74.3K +29 +6%
IC
7
Ikarian Capital
Texas
$955K +$113K +44 +10%
Northern Trust
8
Northern Trust
Illinois
$860K +$43.6K +17 +4%
PHP
9
Parkman Healthcare Partners
Connecticut
$813K +$5.13K +2 +0.5%
O
10
OrbiMed
New York
$675K
FIA
11
FNY Investment Advisers
New York
$536K +$241K +94 +54%
BCM
12
Bridgeway Capital Management
Texas
$465K
BRWA
13
B. Riley Wealth Advisors
Florida
$454K +$25.6K +10 +5%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$355K +$261K +102 +136%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$343K -$2.56K -1 -0.6%
NAM
16
Nexpoint Asset Management
Texas
$322K -$751K -293 -65%
Macquarie Group
17
Macquarie Group
Australia
$322K
N
18
Nuveen
North Carolina
$221K -$2.56K -1 -0.9%
DC
19
Davenport & Co
Virginia
$202K +$259K +101 New
Squarepoint
20
Squarepoint
New York
$190K +$241K +94 New
Charles Schwab
21
Charles Schwab
California
$189K
Morgan Stanley
22
Morgan Stanley
New York
$184K -$138K -54 -37%
TI
23
Telemetry Investments
New York
$152K +$195K +76 New
BFM
24
Boothbay Fund Management
New York
$145K -$2.56K -1 -1%
Los Angeles Capital Management
25
Los Angeles Capital Management
California
$141K +$179K +70 New

MBIO Hedge Fund Activity: Q1 2020 in Review

64 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2020, worth a combined $24M — down 33% from $35.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new MBIO positions and 5 closed out — a net gain of 9 holders — while 14 added to existing stakes and 15 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $261K. The largest seller was Nexpoint Asset Management, cutting an estimated $751K.

  • 64 institutional investors held Mustang Bio (MBIO) as of Q1 2020, up from 55 in Q4 2019.
  • Funds reported $24M of Mustang Bio stock for Q1 2020, down 33% quarter-over-quarter.
  • 14 funds opened new Mustang Bio positions in Q1 2020 and 5 closed out, a net change of +9 holders.
  • The largest Mustang Bio buyer in Q1 2020 was Acadian Asset Management, an estimated $261K added.
  • The largest Mustang Bio seller in Q1 2020 was Nexpoint Asset Management, an estimated $751K sold.

Based on aggregated 13F filings for Q1 2020.